Paid Clinical Trials in London for Healthy Volunteers

25 recruitingLondon, United Kingdom

London has 25 clinical trials actively recruiting healthy volunteers. These include Phase 1 drug safety studies, bioequivalence trials, vaccine studies, and observational research — most offering financial compensation for participation. Learn which studies pay the most →


Showing 120 of 25 studies

Recruiting
Phase 1Phase 2

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

Healthy VolunteersAnemia, Sickle Cell
Bristol-Myers Squibb184 enrolled34 locationsNCT06481306
Recruiting
Phase 1

A Brain Imaging Study to Assess the Binding of MSP-2020 to Serotonin 5-HT2A Receptors in Healthy Male Adults

Healthy Volunteers
Otsuka Pharmaceutical Development & Commercialization, Inc.18 enrolled1 locationNCT07329621
Recruiting
Phase 1

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

Healthy Volunteers
Alnylam Pharmaceuticals76 enrolled1 locationNCT07295717
Recruiting
Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Healthy
Pfizer6,000 enrolled198 locationsNCT07160244
Recruiting
Not Applicable

Evaluation of Adding Nitrate Into Foods for Regulating Nitric Oxide Bioavailability in Healthy Individuals

Healthy VolunteersVascular FunctionNitric Oxide
Queen Mary University of London30 enrolled1 locationNCT07172425
Recruiting
Phase 1Phase 2

Study of TGM-312-SC01 in Healthy Participants and Adults With MASH

Healthy ParticipantsMASH - Metabolic Dysfunction-Associated Steatohepatitis
Tangram Therapeutics Plc99 enrolled1 locationNCT07427680
Recruiting
Not Applicable

Artificial Intelligence Delivered Cardiac Magnetic Resonance - Prospective Validation

Cardiovascular DiseasesHealthy Volunteers
Imperial College London150 enrolled1 locationNCT06061822
Recruiting
Phase 1Phase 2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Healthy Volunteers, Pulmonary Arterial Hypertension
Novartis Pharmaceuticals232 enrolled85 locationsNCT06649110
Recruiting
Phase 1Phase 2

RIG 101 Trial in Healthy Adults and Adults With Asthma

healthy adult participantsSafety and EfficacyAsthma Exacerbation
RIGImmune Inc.82 enrolled2 locationsNCT07488897
Recruiting
Phase 1

Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet

Healthy
Galmed Pharmaceuticals Ltd32 enrolled1 locationNCT07251712
Recruiting
Phase 1

Phase 1 Study of ADX-626 in Healthy Participants

healthy adult participants
ADARx Pharmaceuticals, Inc.44 enrolled1 locationNCT07081503
Recruiting

Genetic Variants and Regulation of Specialized Pro-resolving Mediator

Cardiovascular DiseasesHealthyInflammatory Disease
Queen Mary University of London200 enrolled1 locationNCT04698291
Recruiting
Phase 1

This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects

Healthy SubjectsHealthy Participant Study
Beam Therapeutics Inc.30 enrolled1 locationNCT07304791
Recruiting
Not Applicable

Personalized Responses to Dietary Composition Trial 3

ObesityHealthyDiabetes+5 more
Zoe Global Limited250,000 enrolled2 locationsNCT04735835
Recruiting
Not Applicable

Identifying Wearable Biomarkers to Monitor Dietary Intake

Blood GlucoseEnergy intakeHealthy Volunteers+4 more
Imperial College London10 enrolled1 locationNCT06398340
Recruiting

Development of Novel MR Techniques Using Volunteer Participants

Healthy
University College, London1,500 enrolled1 locationNCT05943249
Recruiting

Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)

HealthyPulmonary Arterial Hypertension
Imperial College London6 enrolled1 locationNCT05745961
Recruiting
Phase 1

Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects

Healthy Volunteers
GH Research Ireland Limited52 enrolled1 locationNCT06511947
Recruiting

Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

DementiaEpilepsyHealthy+3 more
Neurological Institute of Athens350 enrolled4 locationsNCT05171725
Recruiting
Early Phase 1

The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

Treatment-resistant SchizophreniaHealthy (Controls)Treatment-responsive Schizophrenia
King's College London288 enrolled1 locationNCT06270108
Page 1 of 2Next

Common questions about trials in London

How many paid clinical trials are recruiting healthy volunteers in London?

There are currently 25 clinical trials actively recruiting healthy volunteers in London. This number updates daily as new studies open and existing studies complete enrollment.

How much do clinical trials pay in London?

Compensation varies by study type and duration. Phase 1 inpatient studies typically pay $1,000–$5,000+, outpatient visits may pay $50–$500 each, and bioequivalence studies often pay $1,000–$5,000. Each study listing includes specific compensation details in the consent form.

What types of healthy volunteer studies are available in London?

Common study types include Phase 1 drug safety trials, bioequivalence studies comparing generic and brand-name drugs, vaccine trials, dietary and nutrition studies, and observational research. All listed studies are registered on public registries and approved by ethics committees.

Do I need health insurance to participate?

No. Healthy volunteer studies cover all study-related medical costs. If an adverse event occurs, the trial sponsor is generally responsible for related treatment. Specifics are outlined in each study's informed consent document.